» Articles » PMID: 28974782

Nkx2.5+ Cardiomyoblasts Contribute to Cardiomyogenesis in the Neonatal Heart

Overview
Journal Sci Rep
Specialty Science
Date 2017 Oct 5
PMID 28974782
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

During normal lifespan, the mammalian heart undergoes limited renewal of cardiomyocytes. While the exact mechanism for this renewal remains unclear, two possibilities have been proposed: differentiated myocyte replication and progenitor/immature cell differentiation. This study aimed to characterize a population of cardiomyocyte precursors in the neonatal heart and to determine their requirement for cardiac development. By tracking the expression of an embryonic Nkx2.5 cardiac enhancer, we identified cardiomyoblasts capable of differentiation into striated cardiomyocytes in vitro. Genome-wide expression profile of neonatal Nkx2.5+ cardiomyoblasts showed the absence of sarcomeric gene and the presence of cardiac transcription factors. To determine the lineage contribution of the Nkx2.5+ cardiomyoblasts, we generated a doxycycline suppressible Cre transgenic mouse under the regulation of the Nkx2.5 enhancer and showed that neonatal Nkx2.5+ cardiomyoblasts mature into cardiomyocytes in vivo. Ablation of neonatal cardiomyoblasts resulted in ventricular hypertrophy and dilation, supporting a functional requirement of the Nkx2.5+ cardiomyoblasts. This study provides direct lineage tracing evidence that a cardiomyoblast population contributes to cardiogenesis in the neonatal heart. The cell population identified here may serve as a promising therapeutic for pediatric cardiac regeneration.

Citing Articles

Gastrulation-stage gene expression in mouse embryos foreshadows the development of syndromic birth defects.

Chea S, Kreger J, Lopez-Burks M, MacLean A, Lander A, Calof A Sci Adv. 2024; 10(12):eadl4239.

PMID: 38507484 PMC: 10954218. DOI: 10.1126/sciadv.adl4239.


Nkx2.5: a crucial regulator of cardiac development, regeneration and diseases.

Cao C, Li L, Zhang Q, Li H, Wang Z, Wang A Front Cardiovasc Med. 2023; 10:1270951.

PMID: 38124890 PMC: 10732152. DOI: 10.3389/fcvm.2023.1270951.


The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review.

Shafi O, Siddiqui G, Jaffry H BMC Cancer. 2023; 23(1):1245.

PMID: 38110859 PMC: 10726542. DOI: 10.1186/s12885-023-11723-3.


Leveraging 3D Bioprinting and Photon-Counting Computed Tomography to Enable Noninvasive Quantitative Tracking of Multifunctional Tissue Engineered Constructs.

Gil C, Evans C, Li L, Allphin A, Tomov M, Jin L Adv Healthc Mater. 2023; 12(31):e2302271.

PMID: 37709282 PMC: 10842604. DOI: 10.1002/adhm.202302271.


Nucleosome proteostasis and histone turnover.

Arrieta A, Vondriska T Front Mol Biosci. 2022; 9:990006.

PMID: 36250018 PMC: 9563994. DOI: 10.3389/fmolb.2022.990006.


References
1.
Hsueh Y, Wu J, Yu C, Wu K, Hsieh P . Prostaglandin E₂ promotes post-infarction cardiomyocyte replenishment by endogenous stem cells. EMBO Mol Med. 2014; 6(4):496-503. PMC: 3992076. DOI: 10.1002/emmm.201303687. View

2.
Olson E, Schneider M . Sizing up the heart: development redux in disease. Genes Dev. 2003; 17(16):1937-56. DOI: 10.1101/gad.1110103. View

3.
Ivanova A, Signore M, Caro N, Greene N, Copp A, Martinez-Barbera J . In vivo genetic ablation by Cre-mediated expression of diphtheria toxin fragment A. Genesis. 2005; 43(3):129-35. PMC: 2233880. DOI: 10.1002/gene.20162. View

4.
Kattman S, Witty A, Gagliardi M, Dubois N, Niapour M, Hotta A . Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 2011; 8(2):228-40. DOI: 10.1016/j.stem.2010.12.008. View

5.
Jopling C, Sleep E, Raya M, Marti M, Raya A, Izpisua Belmonte J . Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature. 2010; 464(7288):606-9. PMC: 2846535. DOI: 10.1038/nature08899. View